The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A first-in-human, open-label, phase I trial of daily oral zelenirstat, an NMT inhibitor, in patients with relapsed/refractory advanced cancer including gastrointestinal cancers.
 
Jennifer L. Spratlin
Honoraria - Celgene; Eisai; Lilly/ImClone; Sanofi; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Celgene; Eisai; Lilly/ImClone; Sanofi; Taiho Pharmaceutical
Research Funding - Celgene (Inst); Sanofi
Travel, Accommodations, Expenses - Astellas Pharma
 
Randeep S. Sangha
Honoraria - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Lilly; Merck; Pfizer; Roche/Genentech; Sanofi; Takeda; Teva
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Lilly; Merck; Novartis; Roche/Genentech; Sanofi; Takeda; Teva; Teva
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck Serono (Inst); MorphoSys (Inst); Novartis (Inst); Pharmacyclics (Inst); Roche (Inst); Takeda (Inst)
 
Rahima Jamal
Consulting or Advisory Role - BMS; Medison
Research Funding - alkermes (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); BioNTech SE (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Evelo Biosciences (Inst); Immunocore (Inst); Iovance Biotherapeutics (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pacylex (Inst); Pfizer (Inst); Roche/Genentech (Inst); Surface Oncology (Inst); Takeda (Inst); VelosBio/Merck (Inst)
 
Erwan Beauchamp
Employment - Pacylex
Leadership - Pacylex
Stock and Other Ownership Interests - Pacylex
Research Funding - Pacylex
Patents, Royalties, Other Intellectual Property - Pacylex
Travel, Accommodations, Expenses - Pacylex
 
Luc G. Berthiaume
Employment - Pacylex
Stock and Other Ownership Interests - Pacylex
Research Funding - Pacylex
Patents, Royalties, Other Intellectual Property - Pacylex
Travel, Accommodations, Expenses - Pacylex
 
John Robert Mackey
Employment - Pacylex
Leadership - illumiSonics
Stock and Other Ownership Interests - illumiSonics; Pacylex; SMHeartCard
Honoraria - Pfizer
Consulting or Advisory Role - Fe Pharmaceuticals; Viatris
Patents, Royalties, Other Intellectual Property - Patents surrounding technology related to SMHeartCard Inc.
Travel, Accommodations, Expenses - illumiSonics; Pacylex